Cartesian Therapeutics, Inc. (RNAC)
(Delayed Data from NSDQ)
$13.75 USD
+0.38 (2.84%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $13.83 +0.08 (0.58%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.78 | 0.00% |
Earnings Summary
For their last quarter, Cartesian Therapeutics, Inc. (RNAC) reported earnings of $0.54 per share, beating the Zacks Consensus Estimate of $-0.81 per share. This reflects a positive earnings surprise of 166.67%. Look out for RNAC's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.78 per share, reflecting a year-over-year increase of 67.5%.
Earnings History
Price & Consensus
Zacks News for RNAC
Amicus Therapeutics (FOLD) Q2 Earnings and Revenues Top Estimates
RNAC: What are Zacks experts saying now?
Zacks Private Portfolio Services